Sun Young Kim Selected Research

Biomarkers (Surrogate Marker)

1/2023	CEA dynamics for predicting response after anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.
10/2022	Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability‒High Colon Cancer.
1/2022	Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.
6/2021	The Role of Sex-specific Long Non-coding RNAs in Cancer Prevention and Therapy.
11/2018	Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.
1/2018	Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer.
3/2017	A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis.
10/2016	Loss of Tuberous Sclerosis Complex 2 (TSC2) as a Predictive Biomarker of Response to mTOR Inhibitor Treatment in Patients with Hepatocellular Carcinoma.
4/2016	Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment.
1/2016	Pyruvate Kinase M2: A Novel Biomarker for the Early Detection of Acute Kidney Injury.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sun Young Kim Research Topics

Disease

114	Neoplasms (Cancer) 05/2024 - 04/2005
61	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 02/2009
49	Rectal Neoplasms (Rectal Cancer) 01/2022 - 03/2010
22	Neoplasm Metastasis (Metastasis) 07/2022 - 02/2002
17	Colonic Neoplasms (Colon Cancer) 01/2023 - 02/2009
11	Stomach Neoplasms (Stomach Cancer) 01/2019 - 10/2005
10	Adenocarcinoma 11/2023 - 10/2005
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2011
9	Inflammation (Inflammations) 01/2020 - 08/2010
6	Disease Progression 01/2023 - 11/2012
6	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2008
6	Infections 03/2022 - 10/2011
5	Nausea 11/2023 - 02/2010
5	Carcinoma (Carcinomatosis) 07/2017 - 06/2007
4	Vomiting 11/2023 - 02/2010
4	Neutropenia 11/2023 - 05/2013
4	Microsatellite Instability 01/2022 - 05/2017
4	Type 2 Diabetes Mellitus (MODY) 04/2021 - 05/2007
4	Hypoxia (Hypoxemia) 07/2015 - 07/2009
3	Pain (Aches) 01/2024 - 10/2010
3	Fatigue 10/2022 - 07/2010
3	Tuberculosis (Tuberculoses) 03/2022 - 02/2010
3	Thrombocytopenia (Thrombopenia) 01/2021 - 10/2014
3	Sepsis (Septicemia) 12/2020 - 01/2018
3	Hematologic Neoplasms (Hematological Malignancy) 10/2018 - 04/2006
3	Guillain-Barre Syndrome 07/2018 - 03/2013
3	Margins of Excision 04/2018 - 07/2010
3	Pathologic Complete Response 03/2017 - 02/2009
3	Carcinogenesis 10/2016 - 05/2014
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016 - 01/2007
3	Necrosis 04/2014 - 09/2009
2	Headache (Headaches) 01/2024 - 01/2016
2	Cluster Headache (Cluster Headaches) 01/2024 - 01/2023
2	Migraine Disorders (Migraine) 01/2024 - 01/2023
2	Triple Negative Breast Neoplasms 01/2024 - 05/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2023 - 11/2018
2	Ovarian Neoplasms (Ovarian Cancer) 04/2023 - 02/2010
2	Diarrhea 10/2022 - 04/2014
2	Brain Diseases (Brain Disorder) 01/2022 - 11/2006
2	Diabetes Mellitus 04/2021 - 02/2013
2	Colitis 10/2020 - 09/2017
2	Non-alcoholic Fatty Liver Disease 11/2019 - 11/2015
2	Glaucoma 11/2019 - 07/2012

Drug/Important Bio-Agent (IBA)

21	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 06/2009
15	Capecitabine (Xeloda)FDA Link 01/2021 - 02/2008
15	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2007
13	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2007
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2013
11	Cetuximab (Erbitux)FDA Link 01/2022 - 06/2009
9	Carcinoembryonic AntigenIBA 01/2023 - 07/2010
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 04/2008
8	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 12/2012
7	Bevacizumab (Avastin)FDA Link 01/2021 - 07/2009
7	Leucovorin (Folinic Acid)FDA Link 01/2021 - 04/2013
7	ErbB Receptors (EGF Receptor)IBA 01/2018 - 06/2009
6	Messenger RNA (mRNA)IBA 12/2019 - 09/2007
6	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 01/2007
5	Therapeutic UsesIBA 05/2024 - 02/2015
5	SteroidsIBA 03/2022 - 02/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2012
5	Tyrosine Kinase InhibitorsIBA 12/2019 - 03/2012
4	RNA (Ribonucleic Acid)IBA 01/2024 - 02/2017
4	Phosphotransferases (Kinase)IBA 01/2024 - 08/2010
4	Immunoglobulin G (IgG)IBA 01/2021 - 09/2007
4	AntigensIBA 01/2018 - 02/2010
3	Transcription Factors (Transcription Factor)IBA 01/2024 - 05/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 01/2012
3	Dextran SulfateIBA 01/2023 - 09/2017
3	Monoclonal AntibodiesIBA 01/2023 - 09/2015
3	Calcibiotic Root Canal SealerIBA 11/2022 - 11/2013
3	Lactic Acid (Lactate)FDA LinkGeneric 10/2022 - 07/2016
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 01/2008
3	Gefitinib (Iressa)FDA Link 11/2018 - 02/2014
3	Epithelial Cell Adhesion MoleculeIBA 07/2017 - 10/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 11/2010
3	Capsules (Microcapsules)IBA 10/2013 - 09/2012
2	Mitochondrial DNA (mtDNA)IBA 03/2024 - 06/2009
2	ChromatinIBA 01/2024 - 01/2020
2	Sirolimus (Rapamycin)FDA Link 01/2024 - 10/2016
2	Annexin A2 (Annexin II)IBA 01/2024 - 11/2013
2	ibrutinibIBA 11/2023 - 10/2018
2	Epidermal Growth Factor (EGF)IBA 01/2023 - 07/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 09/2009
2	Estrogens (Estrogen)FDA Link 01/2022 - 05/2013
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 06/2021
2	CKD-497IBA 01/2021 - 07/2020
2	AcidsIBA 12/2020 - 05/2014
2	regorafenibIBA 12/2019 - 07/2019

Therapy/Procedure

44	Drug Therapy (Chemotherapy) 01/2024 - 02/2009
43	Therapeutics 05/2024 - 01/2003
41	Chemoradiotherapy 01/2022 - 03/2010
10	Radiotherapy 07/2022 - 06/2010
9	Adjuvant Chemotherapy 11/2023 - 07/2010
6	Neoadjuvant Therapy 01/2021 - 07/2010
4	Palliative Care (Palliative Therapy) 01/2022 - 07/2010
3	Salvage Therapy 11/2017 - 11/2010
3	Metastasectomy 06/2013 - 02/2009
2	Drug Tapering 11/2023 - 01/2021
2	Radiofrequency Ablation 07/2022 - 07/2013
2	Resuscitation 04/2020 - 01/2018